<?xml version="1.0"?>
<notificationOfRemoval>

    <schemaVersion>X0203</schemaVersion>

    <exchange>
        <cik>0001354457</cik>
        <entityName>Nasdaq Stock Market LLC</entityName>
    </exchange>

    <issuer>
        <cik>0001290149</cik>
        <entityName>Sierra Oncology, Inc.</entityName>
        <fileNumber>001-37490</fileNumber>
        <address>
            <street1>2150 - 885 West Georgia St</street1>
            <street2></street2>
            <city>Vancouver</city>
            <stateOrCountryCode>A1</stateOrCountryCode>
            <stateOrCountry>BRITISH COLUMBIA, CANADA</stateOrCountry>
            <zipCode>V6C 3E8 CA</zipCode>
        </address>
        <telephoneNumber>647-393-6739</telephoneNumber>
    </issuer>

    <descriptionClassSecurity>Common stock</descriptionClassSecurity>

    <ruleProvision>17 CFR 240.12d2-2(a)(3)</ruleProvision>

    <signatureData>
        <signatureName>Tara Petta</signatureName>
        <signatureTitle>AVP</signatureTitle>
        <signatureDate>2022-07-01</signatureDate>
    </signatureData>
</notificationOfRemoval>